Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Direct Mouse Genotyping Kit: PCR Workflow
2026-08-24
The Direct Mouse Genotyping Kit K1025 releases genomic DNA from mouse tissue lysates for immediate PCR, avoiding conventional DNA purification during routine screening. It is appropriate for endpoint genotyping and high-throughput workflows, but purified DNA should be used when downstream applications require a cleaner or more extensively characterized template.
-
Clozapine N-oxide for Temporal Circuit Assays
2026-08-24
Clozapine N-oxide (CNO) enables causal testing of engineered neural circuits, but its greatest value emerges when ligand timing is aligned with activity-dependent ensemble labeling. This guide translates remote-memory findings into rigorous chemogenetic assay design and interpretation.
-
Magneto-Piezoelectric Scaffolds for Infected Bone Repair
2026-08-23
This ACS Nano study develops a dual-responsive scaffold that combines magnetic biofilm disruption with ultrasound-driven immune modulation for infectious bone defects. By targeting Icam1+ macrophages and restoring oxidative phosphorylation through JAK2-STAT3 signaling, the platform links infection control with immune-supported bone regeneration.
-
ACSL1 and Mitophagy in Bleomycin Fibrosis Models
2026-08-22
The reference study identifies ACSL1 as a potential regulator of pulmonary fibrosis through mitochondrial protection and PINK1/Parkin-mediated mitophagy. Using patient transcriptomic datasets plus bleomycin-based cell and rat models, it connects ACSL1 loss with mitochondrial injury and shows that ACSL1 restoration or MitoQ treatment can reduce fibrotic damage.
-
Dronedarone (Multaq) Workflows for AF Research
2026-08-22
Build reproducible atrial fibrillation and atrial flutter assays with Dronedarone (Multaq), from solvent handling through automated patch clamp. This workflow distinguishes broad antiarrhythmic pharmacology from direct KCa2-channel effects while providing practical controls for solubility, vehicle exposure, and concentration selection.
-
SUCLG1, Histone Succinylation, and AML
2026-08-21
This Cell Reports study identifies SUCLG1 as a metabolic regulator of histone succinylation and leukemogenic transcription in acute myeloid leukemia. Its findings connect mitochondrial succinyl-CoA handling to BRD4–chromatin engagement, leukemia-cell proliferation, and disease progression in xenograft models, suggesting a mechanistic route for studying metabolism-dependent epigenetic vulnerabilities.
-
Deferasirox, Lysosomal Stress, and Translational Leverage
2026-08-20
Deferasirox is more than an oral iron chelator for iron overload: it is a mechanistic probe for studying how iron availability, mitochondrial ROS, myeloid differentiation, and lysosomal stress intersect. This article connects the TCF25–V-ATPase–ferritinophagy axis to translational iron-chelation research while defining the experiments needed to distinguish hypothesis from evidence.
-
Rotigotine hydrochloride Assay Guide
2026-08-20
A scenario-driven guide to using Rotigotine hydrochloride (SKU A3777) in cell viability, proliferation, cytotoxicity, and dopaminergic signaling workflows. It connects concentration selection, receptor interpretation, solution preparation, translational evidence, and vendor evaluation to practical laboratory decisions.
-
Plerixafor (AMD3100) Experimental Workflow Guide
2026-08-19
Plerixafor (AMD3100) provides a practical way to interrogate CXCL12/CXCR4 signaling across cancer migration, stem-cell trafficking, and immune-cell redistribution. This workflow-focused guide covers assay design, benchmark comparisons, formulation, and troubleshooting for more reproducible results.
-
Platelet Extravasation in Tumors: CXCR4 Control
2026-08-19
The reference study establishes that platelet entry into tumors is an actively regulated form of transendothelial migration rather than a passive consequence of vascular damage. It identifies stromal CXCL12–CXCR4 signaling, platelet FAK and PECAM-1, and distinct granule-release pathways as separable control points linking platelet trafficking with tumor growth.
-
Drosophila Keap1 Nuclear Condensates Under Oxidative Stress
2026-08-18
This study identifies a stress-responsive nuclear condensate function for Drosophila Keap1 (dKeap1), linking its subcellular behavior to domain architecture and intrinsically disordered regions. Fluorescence imaging, FRAP, domain deletions, and in vitro reconstitution show that the dKeap1 C-terminal region promotes condensate formation, whereas the Kelch domain restrains it.
-
Caspase-3 Colorimetric Assay Kit: Practical Guide
2026-08-18
The Caspase-3 Colorimetric Assay Kit provides a plate- or spectrophotometer-based method for measuring DEVD-dependent caspase-3 activity in biological samples and comparing activity with controls. It is intended for biochemical apoptosis research, including Alzheimer's disease research, but should not be used as an in vivo or clinical diagnostic readout.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-17
Saito and colleagues established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids can be cryopreserved, propagated, and differentiated into epithelial cells with transporter and CYP3A activity, providing a more human-relevant platform for intestinal absorption and drug-metabolism research.
-
Zolmitriptan: A Mechanistic Guide for Assays
2026-08-17
Zolmitriptan is a selective 5-HT1B receptor agonist for investigating migraine and trigeminal signaling. This guide connects receptor-proximal assay design with lessons from lysosome-focused antiviral research while clearly separating established pharmacology from exploratory cross-domain questions.
-
KU-55933: Selective ATM Kinase Inhibitor
2026-08-16
KU-55933 is a potent and selective ATM kinase inhibitor for DNA damage response research and cell-based pathway studies. Product information reports a 13 nM IC50, a 2.2 nM Ki, inhibition of ATM-mediated Akt phosphorylation, and research-use-only status.